190 related articles for article (PubMed ID: 35574016)
1. Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With
Meng T; Zhang W; Zhang R; Li J; Gao Y; Qin Y; Jiao X
Front Endocrinol (Lausanne); 2022; 13():829153. PubMed ID: 35574016
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel FOXL2 mutation in a single family with both types of blepharophimosis‑-ptosis-epicanthus inversus syndrome.
Yang L; Li T; Xing Y
Mol Med Rep; 2017 Oct; 16(4):5529-5532. PubMed ID: 28849110
[TBL] [Abstract][Full Text] [Related]
3. Clinical characterization and identification of five novel FOXL2 pathogenic variants in a cohort of 12 Mexican subjects with the syndrome of blepharophimosis-ptosis-epicanthus inversus.
Chacón-Camacho OF; Salgado-Medina A; Alcaraz-Lares N; López-Moreno D; Barragán-Arévalo T; Nava-Castañeda A; Rodríguez-Uribe G; Lieberman E; Rodríguez-Cabrera L; González-Del Angel A; Borbolla AM; Fernández-Hernández L; Graue-Hernández EO; Zenteno JC
Gene; 2019 Jul; 706():62-68. PubMed ID: 31048069
[TBL] [Abstract][Full Text] [Related]
4. Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.
Yang XW; He WB; Gong F; Li W; Li XR; Zhong CG; Lu GX; Lin G; Du J; Tan YQ
Mol Genet Genomic Med; 2018 Mar; 6(2):261-267. PubMed ID: 29378385
[TBL] [Abstract][Full Text] [Related]
5. Premature ovarian insufficiency as a variable feature of blepharophimosis, ptosis, and epicanthus inversus syndrome associated with c.223C > T p.(Leu75Phe) FOXL2 mutation: a case report.
Grzechocińska B; Warzecha D; Wypchło M; Ploski R; Wielgoś M
BMC Med Genet; 2019 Jul; 20(1):132. PubMed ID: 31366388
[TBL] [Abstract][Full Text] [Related]
6. A novel FOXL2 mutation in two infertile patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Hu J; Ke H; Luo W; Yang Y; Liu H; Li G; Qin Y; Ma J; Zhao S
J Assist Reprod Genet; 2020 Jan; 37(1):223-229. PubMed ID: 31823134
[TBL] [Abstract][Full Text] [Related]
7. The Genetic and Clinical Features of
Méjécase C; Nigam C; Moosajee M; Bladen JC
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33806295
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis of a Novel FOXL2 Indel Mutation in Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I.
Chai P; Li F; Fan J; Jia R; Zhang H; Fan X
Int J Biol Sci; 2017; 13(8):1019-1028. PubMed ID: 28924383
[No Abstract] [Full Text] [Related]
9. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation.
De Baere E; Dixon MJ; Small KW; Jabs EW; Leroy BP; Devriendt K; Gillerot Y; Mortier G; Meire F; Van Maldergem L; Courtens W; Hjalgrim H; Huang S; Liebaers I; Van Regemorter N; Touraine P; Praphanphoj V; Verloes A; Udar N; Yellore V; Chalukya M; Yelchits S; De Paepe A; Kuttenn F; Fellous M; Veitia R; Messiaen L
Hum Mol Genet; 2001 Jul; 10(15):1591-600. PubMed ID: 11468277
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Functional Analyses of Two Missense Mutations in the Transcription Factor FOXL2 in Two Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome.
Li H; Gu Y
Genet Test Mol Biomarkers; 2018 Oct; 22(10):585-592. PubMed ID: 30234390
[TBL] [Abstract][Full Text] [Related]
11. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.
Kim JH; Bae J
J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106
[TBL] [Abstract][Full Text] [Related]
12. Novel FOXL2 mutations in two Chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome.
Xue M; Zheng J; Zhou Q; Hejtmancik JF; Wang Y; Li S
BMC Med Genet; 2015 Sep; 16():73. PubMed ID: 26323275
[TBL] [Abstract][Full Text] [Related]
13. FOXL2 gene mutations and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES): a novel mutation detected in a Chinese family and a statistic model for summarizing previous reported records.
Xu Y; Lei H; Dong H; Zhang L; Qin Q; Gao J; Zou Y; Yan X
Mutagenesis; 2009 Sep; 24(5):447-53. PubMed ID: 19592504
[TBL] [Abstract][Full Text] [Related]
14. Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).
Gulati R; Verdin H; Halanaik D; Bhat BV; De Baere E
Eur J Med Genet; 2014 Oct; 57(10):576-8. PubMed ID: 25192944
[TBL] [Abstract][Full Text] [Related]
15. Analysis of FOXL2 detects three novel mutations and an atypical phenotype of blepharophimosis-ptosis-epicanthus inversus syndrome.
Krepelova A; Simandlova M; Vlckova M; Kuthan P; Vincent AL; Liskova P
Clin Exp Ophthalmol; 2016 Dec; 44(9):757-762. PubMed ID: 27283035
[TBL] [Abstract][Full Text] [Related]
16. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X
Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839
[TBL] [Abstract][Full Text] [Related]
17. Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly.
Shen Q; Zhao X; Ji Y; Chai P
J Craniofac Surg; 2024 Jan-Feb 01; 35(1):e52-e56. PubMed ID: 37938073
[TBL] [Abstract][Full Text] [Related]
18. Missense mutation outside the forkhead domain of FOXL2 causes a severe form of BPES type II.
Haghighi A; Verdin H; Haghighi-Kakhki H; Piri N; Gohari NS; De Baere E
Mol Vis; 2012; 18():211-8. PubMed ID: 22312189
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of FOXL2 gene mutations in 5 families affected with blepharophimosis, ptosis and epicanthus inversus syndrome].
Yang X; Li W; Du J; Yuan S; He W; Zhang Q; Zhong C; Lu G; Tan Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):342-346. PubMed ID: 28604951
[TBL] [Abstract][Full Text] [Related]
20. Blepharophimosis-ptosis-epicanthus inversus syndrome plus: deletion 3q22.3q23 in a patient with characteristic facial features and with genital anomalies, spastic diplegia, and speech delay.
Zahanova S; Meaney B; Łabieniec B; Verdin H; De Baere E; Nowaczyk MJM
Clin Dysmorphol; 2012 Jan; 21(1):48-52. PubMed ID: 21934608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]